Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IINN NASDAQ:NXL NASDAQ:XAIR OTCMKTS:YBGJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIINNInspira Technologies OXY B.H.N.$1.22-4.7%$1.04$0.40▼$1.65$16.16M2.3586,500 shs179,022 shsNXLNexalin Technology$0.99-2.9%$1.10$0.59▼$4.49$17.52M3.69126,526 shs38,039 shsXAIRBeyond Air$2.80+1.4%$3.55$2.73▼$13.52$12.81M0.25387,013 shs84,556 shsYBGJYubo International Biotech$0.04$0.07$0.03▼$0.54$4.30M3.74248,571 shs20,000 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIINNInspira Technologies OXY B.H.N.-4.69%-3.17%-20.78%+125.51%+25.24%NXLNexalin Technology-2.94%-3.88%+4.21%-18.85%-5.71%XAIRBeyond Air+1.45%-6.98%-26.24%-25.77%-72.26%YBGJYubo International Biotech0.00%-10.25%-51.49%-59.66%-71.05%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIINNInspira Technologies OXY B.H.N.1.6726 of 5 stars3.53.00.00.00.01.70.0NXLNexalin Technology2.9117 of 5 stars3.55.00.00.02.51.70.0XAIRBeyond Air4.0101 of 5 stars3.72.00.03.52.20.81.3YBGJYubo International BiotechN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIINNInspira Technologies OXY B.H.N. 3.00Buy$2.0063.93% UpsideNXLNexalin Technology 3.00Buy$5.00405.05% UpsideXAIRBeyond Air 3.50Strong Buy$25.50810.71% UpsideYBGJYubo International Biotech 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest YBGJ, NXL, IINN, and XAIR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025XAIRBeyond AirD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025XAIRBeyond AirD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$11.006/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$2.00(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/A$0.34 per shareN/ANXLNexalin Technology$170K100.05N/AN/A$0.28 per share3.54XAIRBeyond Air$3.70M3.51N/AN/A$3.32 per share0.84YBGJYubo International BiotechN/AN/AN/AN/A($0.03) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIINNInspira Technologies OXY B.H.N.-$11.05MN/A0.00∞N/AN/AN/AN/AN/ANXLNexalin Technology-$7.61M-$0.83N/A∞N/A-6,529.77%-277.92%-245.37%8/14/2025 (Estimated)XAIRBeyond Air-$46.62M-$15.80N/AN/AN/A-1,258.46%-233.96%-113.92%8/12/2025 (Estimated)YBGJYubo International Biotech-$1.77M-$0.01N/A∞N/AN/AN/A-124.79%N/ALatest YBGJ, NXL, IINN, and XAIR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q1 2026XAIRBeyond Air-$0.08N/AN/AN/A$1.75 millionN/A8/6/2025Q2 2025NXLNexalin TechnologyN/A-$0.10N/A-$0.10N/AN/A6/17/2025Q4 2025XAIRBeyond Air-$2.80-$1.80+$1.00-$0.09$1.39 million$1.15 million5/13/2025Q1 2025NXLNexalin Technology-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/AXAIRBeyond AirN/AN/AN/AN/AN/AYBGJYubo International BiotechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIINNInspira Technologies OXY B.H.N.0.092.021.89NXLNexalin TechnologyN/A4.564.25XAIRBeyond Air0.643.202.72YBGJYubo International BiotechN/A0.140.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIINNInspira Technologies OXY B.H.N.12.72%NXLNexalin Technology0.65%XAIRBeyond Air31.50%YBGJYubo International BiotechN/AInsider OwnershipCompanyInsider OwnershipIINNInspira Technologies OXY B.H.N.29.40%NXLNexalin Technology25.26%XAIRBeyond Air19.40%YBGJYubo International Biotech68.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIINNInspira Technologies OXY B.H.N.2012.62 million8.91 millionNot OptionableNXLNexalin Technology317.18 million12.84 millionNot OptionableXAIRBeyond Air704.64 million3.74 millionOptionableYBGJYubo International Biotech20119.82 million37.74 millionNot OptionableYBGJ, NXL, IINN, and XAIR HeadlinesRecent News About These CompaniesYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comYBGJ Yubo International Biotech LimitedMay 24, 2024 | seekingalpha.comForever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion marketJanuary 3, 2024 | scmp.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comSABAH OFFERS TREASURE TROVE OF GENETIC RESOURCES FOR BIOTECH - MINISTERSeptember 10, 2023 | bernama.comBAs biotech conference arrives in Boston, Wu launches push to diversify industryJuly 6, 2023 | wgbh.orgWYubo International Biotech Ltd.June 15, 2023 | wsj.comChemical Engineering (Biotechnology) MEApril 20, 2023 | buffalo.eduBBiotechnology – A Solution to Hunger?February 12, 2023 | un.orgUCovid-19: Bharat Biotech to launch intranasal vaccine on January 26January 23, 2023 | scroll.inSGLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEADDecember 25, 2022 | mypharma-editions.comMBiology newsSeptember 14, 2022 | phys.orgPBiotechnology Act to Crash Cost of Vaccines, Drugs Import, Drive ResearchSeptember 12, 2022 | thisdaylive.comTYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeYBGJ, NXL, IINN, and XAIR Company DescriptionsInspira Technologies OXY B.H.N. NASDAQ:IINN$1.22 -0.06 (-4.69%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$1.07 -0.15 (-12.30%) As of 08/6/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Nexalin Technology NASDAQ:NXL$0.99 -0.03 (-2.94%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$0.93 -0.06 (-6.26%) As of 08/6/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Beyond Air NASDAQ:XAIR$2.80 +0.04 (+1.45%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$2.86 +0.06 (+2.14%) As of 08/6/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.Yubo International Biotech OTCMKTS:YBGJ$0.04 0.00 (0.00%) As of 08/5/2025 10:54 AM EasternYubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Joby Deal Gives Blade New Direction, But Stock Lacks Lift How DigitalOcean's Focus Is Fueling Explosive Growth Disney’s Iger-Led Turnaround Gains Traction Can Celsius Stock Keep Its Momentum Going Any Longer? AMD’s Results Sparked a Sell-Off—But That’s Your Buy Signal Rivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline Does Broadcom Have a VMware Problem? Goldman Eyes Upside in NTNX RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
